You have 9 free searches left this month | to do more
Showing 26 - 50 of
5,447 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Terminated
  • Adult Grade III Lymphomatoid Granulomatosis
  • +116 more
  • brentuximab vedotin
  • +2 more
  • Chicago, Illinois
  • +2 more
2021-08-30
Aug 30, 2021
U
Active, not recruiting
  • Classical Hodgkin Lymphoma
  • +12 more
    • Bedford, Bedfordshire, United Kingdom
    • +8 more
    2022-02-22
    Feb 22, 2022
    M
    Active, not recruiting
    • Adult Nasal Type Extranodal NK/T-cell Lymphoma
    • +20 more
    • Scottsdale, Arizona
    • +1 more
    2022-02-03
    Feb 3, 2022
    B
    Terminated
    • Mantle Cell Lymphoma
    • +4 more
    • cellular immunotherapy
    • Providence, Rhode Island
    • +1 more
    2022-02-23
    Feb 23, 2022
    F
    Terminated
    • Post-Transplant Lymphoproliferative Disorder
    • +6 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +9 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    2021-07-16
    Jul 16, 2021
    N
    Completed
    • Lymphoma, Non-Hodgkin
    • +2 more
      • Mwanza, Tanzania
      • +5 more
      2020-05-21
      May 21, 2020
      C
      Completed
      • Acute Myeloid Leukemia
      • +7 more
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      2020-11-06
      Nov 6, 2020
      C
      Active, not recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia
      • +125 more
      • tetanus-CMV fusion peptide vaccine
      • laboratory biomarker analysis
      • Duarte, California
        City of Hope Medical Center
      2022-02-28
      Feb 28, 2022
      C
      Active, not recruiting
      • Adult Grade III Lymphomatoid Granulomatosis
      • +23 more
      • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
      • +2 more
      • Duarte, California
        City of Hope Medical Center
      2022-02-16
      Feb 16, 2022
      A
      Enrolling by invitation
      • Lymphoma, Follicular
      • +7 more
      • ADI-001
      • Stanford, California
      • +4 more
      2021-08-26
      Aug 26, 2021
      N
      Suspended
      • Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
      • +25 more
      • Birmingham, Alabama
      • +23 more
      2022-03-05
      Mar 5, 2022
      A
      Recruiting
      • Lymphoma, Follicular
      • +7 more
      • ADI-001
      • +4 more
      • Stanford, California
      • +4 more
      2021-08-26
      Aug 26, 2021
      N
      Completed
      • Diffuse Large Cell Lymphoma
      • +2 more
      • Buffalo, New York
      • +4 more
      2021-10-29
      Oct 29, 2021
      S
      Active, not recruiting
      • Acute Leukemias of Ambiguous Lineage
      • +4 more
      • Duarte, California
      • +4 more
      2022-04-04
      Apr 4, 2022
      M
      Recruiting
      • Diffuse Large B Cell Lymphoma
      • +8 more
      • 19(T2)28z1xx CAR T cells
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      2022-02-08
      Feb 8, 2022
      M
      Recruiting
      • Acute Leukemia
      • +27 more
      • HSCT with TBI Regimen
      • HSCT with Non-TBI Regimen
      • Minneapolis, Minnesota
        Masonic Cancer Center at University of Minnesota
      2021-05-21
      May 21, 2021
      C
      Active, not recruiting
      • B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
      • +12 more
      • Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
      • +4 more
      • Duarte, California
        City of Hope Comprehensive Cancer Center
      2022-03-29
      Mar 29, 2022
      U
      Active, not recruiting
      • Acute Lymphoblastic Leukemia
      • Burkitt Lymphoma
      • Leukapheresis
      • +3 more
      • London, United Kingdom
      • +3 more
      2020-11-11
      Nov 11, 2020
      N
      Active, not recruiting
      • Adult Burkitt Lymphoma
      • +4 more
      • Chicago, Illinois
      • +4 more
      2022-02-17
      Feb 17, 2022
      T
      Recruiting
      • Acute Myeloid Leukemia (AML)
      • +4 more
      • Individualized Yoga Intervention Group
      • iPad Activity Control Group
      • Hartford, Connecticut
      • +2 more
      2021-09-16
      Sep 16, 2021
      F
      Recruiting
      • Acute Leukemia
      • +18 more
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +8 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      2022-03-16
      Mar 16, 2022